UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 21, 2020
Accession Number:
Submission Type:
CIK: 0001553643
Company Name: RELMADA THERAPEUTICS, INC.
File Number: 333-245054